Looks like that puts another end to the 'Insider Trading' theory until next time. I guess when you pedal Insider Trading & Pump & Dump theories, there's a good chance one might be attributable.....along with numerous other unknown variables.
Also looks like opportunistic traders have made another quick exit for now.
So what's New from the Shareholder Update:
1Quarterly Report for the period ending 31 December 2015
2Procter & Gamble Final negotiations are underway for the licensing terms covering the introduction of the new multi-product Wave-II device and the upgraded and expanded terms for the continuing Eye Wand device license. The agreements under negotiation will span a number of years, covering the licensing rates, volumes, wholesale pricing, payment terms and intellectual property rights and obligations.
The Company hopes to update the market on the finalisation of these negotiations and license agreements in the near term. long term basis for the sales of the Eye Wand and Wave-II-based products across SK-II’s major markets
Near term New Wave II License and Upgraded and Expanded terms for original Eye Wand. Me likey this.
3Programmable array device platformsexpedite consumer usage validation prior to expected final acceptance. Consumer usage research on these pre-production units is expected to be completed during the first quarter of calendar 2016
The return of this consumer research is a major step towards negotiating the licensing terms and commercialisation of this technology with Coty
Slow and frustrating, but looks like they need and want to get this right.
4 BodyguardOBJ expects to receive results from the UQ clinical trial in the first quarter of calendar 2016
The consumer exit polling is in addition to the results of the clinical trial completed by UQ
Exit Polls are very handy when tweaking final products!
5 DCE and SuperTube platformsDuring the period a program to evaluate OBJ’s Dynamically Configurable Emulsions (DCE) technology’s ability to create liquid patches was evaluated in the skin tone (skin whitening sector) with very positive results. The DCE platform is now highly sought after by both existing and prospective partners of OBJ as a breakthrough technology.
There's that word again - Breakthrough!
6Surface hygieneOBJ has recruited a senior project manager who will focus on the development of the overall business case, market definition, development and testing programs for this exciting new area. As with OBJ’s other end-user product development programs, it is intended to utilise partnering companies with existing global brands to distribute the products once development is completed.
Looks like another Bodyguard approach, which equates to higher long-term revenue in the interest of Shareholders.
7Intellectual property Deed of Letters Patent from Japan’s patent office for the delivery of oral care products
Now that the 4C is out of the way, bring on the expected material Announcements (thanks Abdm). I count approx. 8 possibles for Feb starting next Monday:
Jan/Feb 2016 - 2nd Global Licensing Agreement executed with P&G
Jan/Feb 2016 - 3rd Global Licensing Agreement executed with P&G
Feb/Mar 2016 - Body Guard Global License Option Agreement exercised by P&G
Feb/Mar 2016 - World first successful results reported from BodyGuard Clinical Trial to reverse articular joint degeneration
Feb/Mar 2016 - Global License Agreement inked between BodyGuard Life Sciences and new Distribution partner (RB/Brooks)
Feb/Mar 2016 - Formal Licensing Agreement executed with Coty to commercialise world's first programmable array (dermaportation) technology
Feb/Mar 2016 - Non-deal Roadshow Presentation to large Institutional Investors (Presentation released to market)
Feb/Mar 2016 - Half Yearly Report and Accounts
Mar/Apr 2016 - Full Global Commercial roll-out of Wave II applicator for multiple SK-II products
Apr/May 2016 - L'Oréal executes Global Licensing Agreement for ConnectBeauty (Value-add to Genius App)